Enoxaparin

Overview

4.5 out of 5 (42 Reviews)

Credits

1.00

Post Assessment Questions

4

Start Date

1 Sep 2023

Last Review Date

1 Sep 2023

Expiration Date

31 Aug 2026

Estimated Time To Finish

60 Minutes


 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Enoxaparin is low molecular weight heparin (LMWH) and was first approved for medical use in 1993 and is derived from heparin. It has FDA approval for the following clinical conditions - acute coronary syndromes, deep venous thrombosis (DVT) treatment and prophylaxis, treatment for pulmonary embolism (PE), venous thromboembolism (VTE) treatment, and prophylaxis in a variety of scenarios, percutaneous coronary intervention (PCI), and periprocedural anticoagulation, among others. This activity will highlight the mechanism of action, adverse event profile, pharmacology, monitoring, and relevant interactions of enoxaparin, pertinent for interprofessional team members in treating patients with conditions where this agent is indicated.

UAN: JA4008338-0000-23-1647-H01-P

Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Describe the therapeutic mechanism of action of enoxaparin.
  • Review the many indications for enoxaparin use.
  • Summarize the adverse event profile of enoxaparin use.
  • Explain the importance of improving care coordination among the interprofessional team to enhance the delivery of care for patients when using enoxaparin.

Pharmacy Activity Type:
Disease/Drug Therapy Related


Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Pharmacists: StatPearls, LLC designates this activity for a maximum of 1.00 ACPE credit(s). (UAN: JA4008338-0000-23-1647-H01-P ). Pharmacists should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Ellen L. on 2/4/2022

valuable information that i can apply to my practice every day

Anne C. on 2/11/2022

Emmy K. on 4/7/2022

Amy B. on 5/1/2022

Emily G. on 5/16/2022

None

Kimberly G. on 5/31/2022

Melanie S. on 6/7/2022

Marti W. on 7/10/2022

Louie L. on 7/25/2022

Noah S. on 8/1/2022

Nicole F. on 8/29/2022

Kimber E. on 10/18/2022

Theodore B. on 10/28/2022

Zahra T. on 12/12/2022

Omar M. on 12/26/2022

Avinash G. on 3/30/2023

Jenna M. on 4/30/2023

Urvil P. on 5/5/2023

Mark L. on 6/28/2023

VLADIMIR E. on 7/7/2023

Angeline S. on 7/10/2023

ASEEDU K. on 7/14/2023

Dr Sruthi G. on 7/26/2023

Elizabeth P. on 7/27/2023

Kelli T. on 8/26/2023

Michelle H. on 9/18/2023

Dr. L. on 9/27/2023

Warren L. on 9/25/2023

Cindy D. on 10/11/2023

Rolando E. on 11/3/2023

Marcus T. on 11/12/2023

Pamela P. on 11/25/2023

Kim L. on 11/29/2023

Manish S. on 12/17/2023

Kaman C. on 12/19/2023

Mohamed E. on 12/18/2023

Shreekant P. on 12/18/2023

Nelson M. on 12/24/2023

David C. on 12/30/2023

Rebecca P. on 1/9/2024

Nelson M. on 1/28/2024

Sarah H. on 2/25/2024

Unlimited Pharmacist CE

Stay up to date on the latest medical knowledge with 6673 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7924.5 hours of CE.

Single Activity

Take this single activity

$29 1 activity

6 Month Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$119 per half year per user

1 Year Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$199 per 1 year per user